Evidence map›Paper›PMID 33879853›Full record

ArticleEye (London, England)2021

The UK practice of Anti-VEGF therapy for treatment of retinopathy of prematurity.

Shahanaz B Ahmed, Aisling Higham, Alan Mulvihill, T K J Chan, Gill Adams, Chetan K Patel

Abstract read
In one paragraph

Article in Eye (London, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Safety profile of anesthetic modalities during laser treatment for retinopathy of prematurity: a systematic review.Journal of perinatology : official journal of the California Perinatal Association · 2023
    Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shahanaz B AhmedOxford Eye Hospital, John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK. shahanaz.ahmed@nhs.net.ORCID http://orcid.org/0000-0002-7931-7208
Aisling HighamOxford Eye Hospital, John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.ORCID http://orcid.org/0000-0002-8901-0007
Alan MulvihillRoyal Hospital for Children and Young People, NHS Lothian, Edinburgh, UK.
T K J ChanRoyal Hospital for Children and Young People, NHS Lothian, Edinburgh, UK.
Gill AdamsMoorfields Eye Hospital NHS Foundation Trust, London, UK.ORCID http://orcid.org/0000-0003-1619-798X
Chetan K PatelOxford Eye Hospital, John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.ORCID http://orcid.org/0000-0002-1409-6045

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Retinopathy of PrematurityAngiogenesis InhibitorsBevacizumabHumansInfant, NewbornIntravitreal InjectionsUnited KingdomAngiogenesis InhibitorsBevacizumab

Identifiers

PMID33879853
PMCPMC8377112

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.